Increasing the number of Treg cells by administering IL-2:IL-2 antibody complexes after stroke improved the white matter status and restored neurological function in the long-term, suggesting that Tregs could be a therapeutic target of neural recovery after stroke (11). The gene discussed is IL2; the disease is Stroke.